About chrismoorecm1gmailcom

This author has not yet filled in any details.
So far chrismoorecm1gmailcom has created 29 blog entries.

Bioarray Genetics to Present at the 2019 International Cancer Cluster Showcase

2019-05-16T18:11:56+00:00

Bioarray Genetics to Present at the 2019 International Cancer Cluster Showcase on June 3rd 16-May-2019, For Immediate Release Bioarray Genetics, Inc. announced today that it was selected to present at the 2019 International Cancer Cluster Showcase as part of its North American and European cutting-edge oncology innovations group. Bioarray is [...]

Bioarray Genetics to Present at the 2019 International Cancer Cluster Showcase2019-05-16T18:11:56+00:00

Expression Concordance of 325 Novel RNA Biomarkers between Data Generated by NanoString nCounter and Affymetrix GeneChip

2019-05-16T18:19:35+00:00

Expression Concordance of 325 Novel RNA Biomarkers between Data Generated by NanoString nCounter and Affymetrix GeneChip With the development of new drug combinations and targeted treatments for multiple types of cancer, the ability to stratify categories of patient populations and to develop companion diagnostics has become increasingly important. A panel [...]

Expression Concordance of 325 Novel RNA Biomarkers between Data Generated by NanoString nCounter and Affymetrix GeneChip2019-05-16T18:19:35+00:00

Interview with CEOCFO magazine

2018-09-25T03:50:21+00:00

Bioarray Interview with CEOCFO magazine It was our pleasure to share some thoughts on being a diagnostic startup and what we think the future holds for Bioarray. "At Bioarray, we want to eliminate the error  and fear inherent in cancer treatment by combining gene profiling with machine learning algorithms to identify [...]

Interview with CEOCFO magazine2018-09-25T03:50:21+00:00

Bioarray Genetics Named Innovator of the Month

2018-08-01T21:36:39+00:00

Bioarray Genetics Named "Murphy's Innovator of the Month" WASHINGTON – U.S. Senator Chris Murphy (D-Conn.) announced on Tuesday that Bioarray Genetics, a Farmington biotech company housed at University of Connecticut’s (UConn) Technology Incubation Program (TIP), is “Murphy’s Innovator of the Month.” Bioarray Genetics focuses on using genomics and machine learning to predict the treatment [...]

Bioarray Genetics Named Innovator of the Month2018-08-01T21:36:39+00:00

2018 Entrepreneur of the Year: Scalable Venture

2018-04-25T22:56:57+00:00

2018 CT Entrepreneur of the Year: Scalable Venture April 20th, 2018 New Haven, CT It was with great honor tonight that Bioarray Genetics' CEO  Founder, Marcia Fournier, won the 2018 CT Entrepreneur of the Year Award in the Scalable Ventures category.  Nominations began in January 2018 and were judged by [...]

2018 Entrepreneur of the Year: Scalable Venture2018-04-25T22:56:57+00:00

AACR Abstract: Isolation and detection of breast cancer cells in blood samples using antibody cocktails selected by large-scale genome-wide screening

2018-04-20T05:05:25+00:00

Isolation and detection of breast cancer cells in blood samples using antibody cocktails selected by large-scale genome-wide screening Screening and prevention is critical to reducing breast cancer deaths, and mammography is not an ideal tool. To address this critical unmet need, we developed a panel of cell surface markers whose expression [...]

AACR Abstract: Isolation and detection of breast cancer cells in blood samples using antibody cocktails selected by large-scale genome-wide screening2018-04-20T05:05:25+00:00

AACR Abstract: Genes involved in non-malignant breast phenotypes are widely expressed in multiple cancers and provide novel biomarkers of clinical outcomes and therapeutic response

2018-04-20T05:06:20+00:00

Genes involved in non-malignant breast phenotypes are widely expressed in multiple cancers and provide novel biomarkers of clinical outcomes and therapeutic response We selected novel biomarkers based on non-malignant breast epithelial cell phenotypes and identified 325 genes (BA325) showing 32 significant oncology drug associations. A total of 251 genes out [...]

AACR Abstract: Genes involved in non-malignant breast phenotypes are widely expressed in multiple cancers and provide novel biomarkers of clinical outcomes and therapeutic response2018-04-20T05:06:20+00:00

Bioarray awarded patent for breast cancer treatment predictive test

2018-04-26T20:46:42+00:00

Bioarray Genetics awarded patent for breast cancer treatment predictive test Farmington-based molecular diagnostics company Bioarray Genetics Inc. has received a U.S. patent supporting its lead breast cancer predictive test. The patent covers methods and kits for predicting the effectiveness of breast cancer treatments. The method also generates a report indicating [...]

Bioarray awarded patent for breast cancer treatment predictive test2018-04-26T20:46:42+00:00

Bioarray Genetics Presents at the 40th Annual San Antonio Breast Cancer Symposium

2018-04-26T20:57:56+00:00

Bioarray Genetics Presents at the 40th Annual San Antonio Breast Cancer Symposium Bioarray Genetics announced today that the Company will be presenting a pivotal study at the upcoming 40th Annual San Antonio Breast Cancer Symposium on December 7th. Bioarray conducted a 582-patient clinical validation study that confirms the company's lead [...]

Bioarray Genetics Presents at the 40th Annual San Antonio Breast Cancer Symposium2018-04-26T20:57:56+00:00

Bioarray Genetics Series B Financing

2018-04-26T20:52:13+00:00

Bioarray Genetics Receives $4M in Series B Equity Financing Bioarray Genetics, a personalized medicine startup, announced today that it has received $4 million in Series B Equity Financing from Quark Venture and GF Securities through their Global Health Science Fund and Connecticut Innovations. Bioarray, a personalized medicine [...]

Bioarray Genetics Series B Financing2018-04-26T20:52:13+00:00